# Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

> **NCT02193698** · PHASE2 · COMPLETED · sponsor: **Chiba University** · enrollment: 5 (actual)

## Conditions studied

- POEMS Syndrome

## Interventions

- **DRUG:** Lenalidomide+Dexamethasone

## Key facts

- **NCT ID:** NCT02193698
- **Lead sponsor:** Chiba University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-10
- **Final completion:** 2016-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193698, "Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02193698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*